Toviaz
Loading...Toviaz Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
- to make a child sleepy
- with any other product containing diphenhydramine, even one used on skin
- breathing problem such as emphysema or chronic bronchitis
- glaucoma
- trouble urinating due to an enlarged prostate gland
taking sedatives or tranquilizers.
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
- excitability may occur, especially in children
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
- to make a child sleepy
- with any other product containing diphenhydramine, even one used on skin
- breathing problem such as emphysema or chronic bronchitis
- glaucoma
- trouble urinating due to an enlarged prostate gland
taking sedatives or tranquilizers.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
- temporarily relieves these symptoms due to the common cold:
- runny nose
- sneezing
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Toviaz Manufacturers
- Cardinal Health
![Toviaz (Fesoterodine Fumarate) Tablet, Film Coated, Extended Release [Cardinal Health]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Toviaz | Meijer
take every 4 to 6 hours, or as directed by a doctor do not take more than 6 times in 24 hours adults and children 12
years and over 1 to 2 tablets
children 6 to under 12
years 1 tablet
children under 6 years do not use - Physicians Total Care, Inc.
Toviaz | Physicians Total Care, Inc.
The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.
The daily dose of Toviaz should not exceed 4 mg in the following populations:
Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.5, 5.7, 5.8); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].
Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.
- Pfizer Laboratories Div Pfizer Inc
Toviaz | Pfizer Laboratories Div Pfizer Inc
The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.
The daily dose of Toviaz should not exceed 4 mg in the following populations:
Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.6, 5.8, 5.9); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].
Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.
- U.s. Pharmaceuticals
Toviaz | U.s. Pharmaceuticals
The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.
The daily dose of Toviaz should not exceed 4 mg in the following populations:
Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.6, 5.8, 5.9); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].
Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.
![Toviaz (Fesoterodine Fumarate) Tablet, Film Coated, Extended Release [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fead426f-b955-4b41-8553-f102d17afa3a&name=6156.jpg)
![Toviaz (Fesoterodine Fumarate) Tablet, Film Coated, Extended Release [Pfizer Laboratories Div Pfizer Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1&name=toviaz-07.jpg)
![Toviaz (Fesoterodine Fumarate) Tablet, Film Coated, Extended Release [U.s. Pharmaceuticals]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4f01dced-195a-4712-a614-d68012bc29df&name=toviaz-07.jpg)
Login To Your Free Account